Skip to main content

COVID-19 & cancer


24-02-2022 | ASCO GU 2022 | Conference coverage | Video

Mapping the impact of COVID-19 on genitourinary cancers

Chris Labaki takes us through his study evaluating temporal changes in the screening, diagnosis, and surgical treatment of genitourinary malignancies during the first year of the COVID-19 pandemic.

12-01-2022 | COVID-19 | News

Antibody response to COVID-19 vaccine strengthened after third dose in cancer patients

Research from three countries adds support for the use of a booster dose of vaccines against SARS-CoV-2 in people with cancer, especially those undergoing active anticancer treatment.

03-11-2021 | COVID-19 | News

SARS-CoV-2 humoral, cellular immunity in people with cancer characterized

Two papers from the prospective, longitudinal UK CAPTURE consortium shed light on the humoral and cellular immune response to SARS-CoV-2 vaccination and infection in patients with cancer.

More on COVID-19 in cancer patients

More guidance for oncologists

Stay informed with Medicine Matters

Get the latest developments in breast, lung, & GU cancers delivered straight to your inbox